MONDAY, MARCH 19, 2018

HIV therapies without Efavirenz proven effective

Drug combinations built around Efavirenz are often the first treatments recommended when patients are diagnosed with HIV. Read More »

Vaccination workers support Iraq against polio and cholera

Exactly 12,703 vaccination teams have united in a nationwide campaign in Iraq to vaccinate children against polio and to fight against the spread of cholera. Read More »

Reps. Crenshaw, Meeks congratulate Nobel Prize scientists

U.S. Reps. Ander Crenshaw (R–FL) and Gregory Meeks (D–NY), co-chairs of Congressional Caucus on Malaria and Neglected Tropical Diseases, recently congratulated Nobel Prize scientists for their progress against malaria and parasitic diseases. Read More »

Drug shows promise in fighting malaria during pregnancy if asymptomatic patients can be identified

The Liverpool School of Tropical Medicine (LSTM) has found that the new drug dihydroartemisinin-piperaquine (DP) may be a promising alternative in malaria treatments for pregnant women.  Read More »

Health officials take proactive measures against possible flu pandemics

Although October through May is typically known as the flu season, the influenza virus actually causes illnesses all year long. Read More »

Virginia's low-income HIV patients benefit from Affordable Care Act

A recent study conducted by the University of Virginia School of Medicine shows that the Virginia’s HIV patients benefit from the Affordable Care Act. Read More »

Human Vaccines Project, MedImmune partner to speed vaccine research and development

The Human Vaccines Project recently welcomed its latest member, MedImmune, to help speed the research and development process for vaccines as well as immunotherapies that are used for cancer and infectious diseases. Read More »

Flu vaccinations for children could diminish U.K. disease burden

Expanding flu vaccination administration to children throughout the U.K. may be a cost-effective way to decrease the current disease burden among the general population in the U.K. Read More »

Los Alamos lab releases new HIV-1 vaccine design insights

Scientists from Los Alamos National Laboratory recently developed a computational model to transform how researchers evaluate possibilities for vaccines for HIV-1. Read More »

University of Maryland launches HIV vaccine trial

Researchers from the University of Maryland’s Institute of Human Virology in Baltimore recently launched clinical trials for an HIV vaccine candidate. Read More »

Study cites children's pain as reason parents pass on vaccines

Studies have demonstrated that children feeling pain from their vaccinations is a leading cause of anxiety for childhood caregivers, which may contribute to parents stalling on providing childhood vaccinations. Read More »

Center for Infectious Disease Research finds promising TB treatments

Scientists from the Center for Infectious Disease Research, the biggest independent nonprofit based in the U.S. that specializes in research for infectious diseases, has partnered with GlaxoSmithKline’s Tres Cantos Open Lab Foundation to advance treatments for Mycobacterium tuberculosis (Mtb). Read More »

ECDC studies reasons for vaccine hesitancy

The European Centre for Disease Prevention and Control recently released a report with evidence to help health professionals better understand the vaccine hesitancy within the E.U./European Economic Area nations. Read More »

Novel anti-Ebola drug may safeguard non-human primates

The results showed that GS-5734 is the first small-molecule antiviral agent that shows robust therapeutic efficacy within monkey subjects infected with Ebola. Read More »

World Health Organization marks progress in fight against tuberculosis

The Western Pacific Regional Office of the World Health Organization (WHO) recently reported that it has made significant progress in decreasing the tuberculosis (TB) burden, but there is still a lot of work to do. Read More »

Novel aerosol vaccine for TB shows promise

A team of researchers has utilized funding from the National Institute of Allergy and Infectious Diseases (NIAID), a branch of the National Institutes of Health (NIH), to create an investigational aerosol vaccine to protect people against tuberculosis (TB). Read More »

Study finds ebola can continue in survivors’ semen following illness

The Centers for Disease Control and Prevention (CDC) recently released preliminary findings from a study suggesting that male survivors of Ebola can still have Ebola virus fragments in their semen at least nine months after contracting the illness. Read More »

Meningitis vaccines may benefit individuals and family members

A study recently published in Health Economics states that meningitis vaccines may benefit individuals as well as their close family members. Read More »

Louisiana reports 55th West Nile virus case of 2015

The Louisiana Department of Health and Hospitals (DHH) confirmed another West Nile virus case this week, the 55th for 2015. Read More »

Global center launches to develop products to stem infectious disease

Sanofi Pasteur, Sanofi’s vaccine division, recently announced that it has launched a Global Health Vaccine Center of Innovation (GHVCI) as part of its collaboration with the Infectious Disease Research Institute (IDRI), a nonprofit, global-health institute that specializes in creating new products for infectious diseases. Read More »